Most studies examining the impact of alcohol-dependence (AD) treatment on quality-of-life (QOL) have looked at psychosocial treatments. This study looked at the impact of pharmacotherapy on QOL, ...

Naloxone (Narcan), naltrexone (Trexan; ReVia), and Vivitrol (long-acting injectable naltrexone) changed addiction medicine into a profession with FDA-approved treatments for opioid overdose reversal, ...

Long–acting injections of the drug naltrexone, combined with psychotherapy, significantly reduced heavy drinking in patients being treated for alcohol dependence, according to a study in the Journal ...

Expert Rev Clin Pharmacol. 2012;5(4):427-435. Naltrexone is relatively well tolerated, and the primary side effects are gastrointestinal discomfort. Higher doses (above 50 mg/day) have been suggested ...

Although it's been used since the 1980s, naltrexone remains a relatively unknown treatment for alcohol dependency. Costing around £3 per pill, the drug blocks the "euphoric and sedative effects" of ...

If you’ve followed any health news lately, you’ve likely heard about Ozempic and similar drugs. GLP-1 medications, originally developed to treat diabetes, have gained widespread attention for their ...

Recent studies continue to support a decades-old drug as an alternative means of reducing alcohol consumption. The prescription opioid antagonist, called naltrexone, was first approved by the FDA to ...

Share on Pinterest Naltrexone (referred to as the “Ozempic of alcohol”) is a drug that can help reduce alcohol and opioid cravings for people living with substance misuse disorder. vitapix/Getty ...

As millions of Americans battle alcohol abuse problems each year, public health officials suggest that two often overlooked medications might offer relief to some. More than 18 million people abuse or ...

Naltrexone is a generic drug that’s prescribed for opioid use disorder and alcohol use disorder. Naltrexone comes as an oral tablet and belongs to the opioid antagonist drug class. Naltrexone is ...

Expert Rev Clin Pharmacol. 2012;5(4):427-435. Recent comparisons of naltrexone and acamprosate using systematic literature review conclude that, although both drugs are effective as adjuvant therapies ...